Stonegate Capital Partners has issued an update on Viemed Healthcare, Inc. (NASDAQ: VMD), noting that the company's first-quarter 2026 results reflect improving growth quality rather than just reported scale. The analysis, released May 8, 2026, points to sleep, resupply, and maternal health becoming larger contributors to revenue, reducing reliance on legacy ventilation and improving capital efficiency.
Viemed's free cash flow (FCF) conversion improved meaningfully during the quarter. Cash flow from operations (CFFO) increased to $8.1 million from $2.9 million in the same period last year, while trailing twelve-month FCF rose to $36.3 million from $23.3 million at year-end 2025. This stronger cash generation is attributed to the broader service mix as higher-margin segments scale.
The revenue mix continued to shift away from ventilator rentals, which declined to 46.9% of total revenue from 54.4% a year earlier. Meanwhile, commercial payor revenue increased to 23% from 17%, indicating improved payer diversification. The company's sleep and resupply businesses remain the clearest growth drivers: PAP patients grew 57% year-over-year to 35,938, new patient starts increased 42%, and resupply patients rose 47%.
Ventilation services, while still a significant portion of revenue, appear to be navigating the transition related to the National Coverage Determination (NCD). New-start activity has improved and compliance is increasing, though turnover continues to pressure census. Stonegate notes that the overall mix shift is driving stronger FCF conversion as sleep, resupply, and maternal health scale.
For investors, these trends suggest Viemed is becoming less dependent on a single service line and is generating higher cash returns on its capital base. The improvement in commercial payor mix also reduces exposure to government reimbursement risk. The company's ability to grow its patient base in sleep and resupply while maintaining cash flow discipline could support further valuation upside.
Stonegate Capital Partners, a capital markets advisory firm, provides equity research and institutional investor outreach. The full announcement including downloadable images is available here.
